Brammer Bio, LLC Sustainability Profile
Brammer Bio, LLC, a leading player in the biopharmaceutical industry, is headquartered in the United States, with significant operational regions across North America and Europe. Founded in 2018, the company has quickly established itself as a trusted partner in the development and manufacturing of advanced therapies, particularly in the field of gene and cell therapy. Brammer Bio offers a unique suite of services, including viral vector manufacturing and process development, tailored to meet the specific needs of its clients. The company’s commitment to quality and innovation has positioned it as a key contributor to the rapidly evolving landscape of biotherapeutics. With a focus on accelerating the delivery of life-changing therapies, Brammer Bio continues to achieve notable milestones, solidifying its reputation as a leader in the contract development and manufacturing organisation (CDMO) sector.
DitchCarbon Score
How does Brammer Bio, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Brammer Bio, LLC's score of 90 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Brammer Bio, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Thermo Fisher Scientific Inc., which influences its climate commitments and emissions reporting. As part of its corporate family, Brammer Bio inherits climate initiatives and targets from Thermo Fisher Scientific Inc. This includes commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks. However, specific reduction targets or achievements for Brammer Bio itself have not been disclosed. Brammer Bio's climate strategy is aligned with its parent company's broader sustainability goals, which focus on reducing greenhouse gas emissions across all scopes. The absence of direct emissions data suggests that the company is in the process of developing its own specific targets and initiatives, potentially cascading from Thermo Fisher's established practices. In summary, while Brammer Bio, LLC does not currently report specific emissions figures, it is positioned within a corporate structure that prioritises climate action and sustainability, guided by the initiatives of Thermo Fisher Scientific Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Brammer Bio, LLC's Industry?
How Carbon Intensive is Brammer Bio, LLC's Location?
Brammer Bio, LLC's Scope 3 Categories Breakdown
Brammer Bio, LLC's Scope 3 emissions, which decreased by 13% last year and decreased by approximately 15% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Brammer Bio, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Brammer Bio, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
